CSF3R, SETBP1 and CALR mutations in chronic neutrophilic leukemia

Journal of Hematology and Oncology

Volumn 7, Issue 1, 2014, Pages

  Cui, Yajuan ^a   Li, Bing ^a   Gale, Robert Peter ^b   Jiang, Qian ^c   Xu, Zefeng ^a   Qin, Tiejun ^a   Zhang, Peihong ^a   Zhang, Yue ^a   Xiao, Zhijian ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c PEKING UNIVERSITY   (China)

Author keywords

CALR; Chronic neutrophilic leukemia; CNL; CSF3R; Mutation; SETBP1

Indexed keywords

DASATINIB; FEDRATINIB; RUXOLITINIB; CALRETICULIN; CALRETICULIN, HUMAN; CARRIER PROTEIN; COLONY STIMULATING FACTOR RECEPTOR; CSF3R PROTEIN, HUMAN; NUCLEAR PROTEIN; SETBP1 PROTEIN, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CALR GENE; CHRONIC NEUTROPHILIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CSF3R GENE; EXON; FEMALE; GENE; GENE INSERTION; GENE MUTATION; GENE SEQUENCE; HETEROZYGOSITY; HUMAN; INCIDENCE; LABORATORY TEST; MALE; MISSENSE MUTATION; MONOCLONAL IMMUNOGLOBULINEMIA; MUTATIONAL ANALYSIS; SETBP1 GENE; SOMATIC MUTATION; GENETICS; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CALRETICULIN; CARRIER PROTEINS; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; LEUKEMIA, NEUTROPHILIC, CHRONIC; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; POLYMERASE CHAIN REACTION; RECEPTORS, COLONY-STIMULATING FACTOR; TUMOR MARKERS, BIOLOGICAL;

EID: 84923230914     PISSN: None     EISSN: 17568722     Source Type: Journal    
DOI: 10.1186/s13045-014-0077-1     Document Type: Article

References (12)

1. Bain BJ, Brunning RD, Vardiman JW, Thiele J: Chronic neutrophilic leukemia. In WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. Edited by Swerdlow SH, Campo E, Lee Harris N. Lyon, France: IARC Press; 2008:38-39.
2. Maxson JE, Gotlib J, Pollyea DA, Fleischman AG, Agarwal A, Eide CA, Bottomly D, Wilmot B, McWeeney SK, Tognon CE, Pond JB, Collins RH, Goueli B, Oh ST, Deininger MW, Chang BH, Loriaux MM, Druker BJ, Tyner JW: Oncogenic csf3r mutations in chronic neutrophilic leukemia and atypical cml. N Engl J Med 2013, 368(19):1781-1790.
3. Pardanani A, Lasho TL, Laborde RR, Elliott M, Hanson CA, Knudson RA, Ketterling RP, Maxson JE, Tyner JW, Tefferi A: CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia. Leukemia 2013, 27(9):1870-1873.
4. Lasho TL, Elliott MA, Pardanani A, Tefferi A: CALR mutation studies in chronic neutrophilic leukemia. Am J Hematol 2014, 89(4):450.
5. Li B, Xu J, Wang J, Gale RP, Xu Z, Cui Y, Yang L, Xing R, Ai X, Qin T, Zhang Y, Zhang P, Xiao Z: Calreticulin mutations in chinese with primary myelofibrosis. Haematologica 2014, [Epub ahead of print].
6. Tefferi A, Thiele J, Vannucchi AM, Barbui T: An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms. Leukemia 2014, 28(7):1407-1413.
7. Gotlib J, Maxson JE, George TI, Tyner JW: The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood 2013, 122(10):1707-1711.
8. Elliott MA, Dewald GW, Tefferi A, Hanson CA: Chronic neutrophilic leukemia (CNL): A clinical, pathologic and cytogenetic study. Leukemia 2001, 15(1):35-40.
9. Nicholson SE, Oates AC, Harpur AG, Ziemiecki A, Wilks AF, Layton JE: Tyrosine kinase JAK1 is associated with the granulocyte-colony-stimulating factor receptor and both become tyrosine-phosphorylated after receptor activation. Proc Natl Acad Sci U S A 1994, 91(8):2985-2988.
10. Corey SJ, Burkhardt AL, Bolen JB, Geahlen RL, Tkatch LS, Tweardy DJ: Granulocyte colony-stimulating factor receptor signaling involves the formation of a three-component complex with Lyn and Syk protein-Tyrosine kinases. Proc Natl Acad Sci U S A 1994, 91(11):4683-4687.
11. Fleischman AG, Maxson JE, Luty SB, Agarwal A, Royer LR, Abel ML, MacManiman JD, Loriaux MM, Druker BJ, Tyner JW: The CSF3R T618I mutation causes a lethal neutrophilic neoplasia in mice that is responsive to therapeutic JAK inhibition. Blood 2013, 122(22):3628-3631.
12. Lasho TL, Mims A, Elliott MA, Finke C, Pardanani A, Tefferi A: Chronic neutrophilic leukemia with concurrent CSF3R and SETBP1 mutations: single colony clonality studies, in vitro sensitivity to JAK inhibitors and lack of treatment response to ruxolitinib. Leukemia 2014, 28(6):1363-1365.